MGUS pathology

preview_player
Показать описание
Tarek H Mouhieddine, MD, Dana-Farber Cancer Institute, Boston, MA, outlines the pathology and prognosis of monoclonal gammopathy of undetermined significance (MGUS) at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.
Рекомендации по теме